Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 15/20 | 1.00 |
| ▸ | CSNK1D | P48730 | 5/20 | 1.00 |
| ▸ | CSNK1E | P49674 | 4/20 | 1.00 |
| ▸ | MAPK13 | O15264 | 9/20 | 0.78 |
| ▸ | GCGR | P47871 | 9/20 | 0.78 |
| ▸ | MAPK12 | P53778 | 9/20 | 0.78 |
| ▸ | MAPK11 | Q15759 | 9/20 | 0.78 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.65 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.64 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.64 |
| ▸ | FRK | P42685 | 1/20 | 0.64 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.64 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.64 |
| ▸ | GSK3B | P49841 | 1/20 | 0.64 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.64 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.64 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17002321 | 1.00 | MAPK14 (1.00) | MAPK14CSNK1DCSNK1EMAPK13GCGR | |
| SCHEMBL19952769 | 0.88 | MAPK14 (0.79) | MAPK14CSNK1DCSNK1EMAPK13GCGR | |
| SCHEMBL2650029 | 0.88 | MAPK14 (1.00) | MAPK14CSNK1DCSNK1EMAPK13GCGR | |
| SCHEMBL26677067 | 0.85 | MAPK14 (0.74) | MAPK14CSNK1DCSNK1EMAPK13GCGR | |
| SCHEMBL22778283 | 0.84 | MAPK14 (0.72) | MAPK14CSNK1DCSNK1EMAPK13GCGR | |
| SCHEMBL30365518 | 0.83 | MAPK14 (1.00) | MAPK14CSNK1DCSNK1EMAPK13GCGR | |
| SCHEMBL17002323 | 0.83 | MAPK14 (1.00) | MAPK14CSNK1DCSNK1EMAPK13GCGR | |
| SCHEMBL17002312 | 0.82 | MAPK14 (1.00) | MAPK14CSNK1DCSNK1EMAPK13GCGR | |
| SCHEMBL30365700 | 0.82 | MAPK14 (1.00) | MAPK14CSNK1DCSNK1EMAPK13GCGR | |
| SCHEMBL30197605 | 0.81 | MAPK14 (1.00) | MAPK14CSNK1DCSNK1EMAPK13GCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115413669-B | Kinase inhibitor and application of composition thereof in improving bacterial wilt resistance of plants | 湖南大学 | 2024-03-15 | — | — | CN | claimed |
| CN-115413669-A | Application of kinase inhibitor and combined agent thereof in improving bacterial wilt resistance of plants | 湖南大学 | 2022-12-02 | — | — | CN | claimed |
| US-12295955-B2 | TTP phosphorylation for the identification of personalized medicines | KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE (SA) | 2025-05-13 | — | — | US | disclosed |
| US-20240390406-A1 | PHOSPHORYLATED TRISTETRAPROLIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR ANTIAGING DRUGS | KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE (SA) | 2024-11-28 | — | — | US | disclosed |
| EP-4467978-A1 | PHOSPHORYLATED TRISTETRAPROLIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR ANTI-AGING DRUGS | King Faisal Specialist Hospital & Research Centre (SA) | 2024-11-27 | — | — | EP | disclosed |
| CN-115413669-B | Kinase inhibitor and application of composition thereof in improving bacterial wilt resistance of plants | 湖南大学 | 2024-03-15 | — | — | CN | disclosed |
| CN-115413669-B | Kinase inhibitor and application of composition thereof in improving bacterial wilt resistance of plants | 湖南大学 | 2024-03-15 | — | — | CN | disclosed |
| US-20230310437-A1 | TTP PHOSPHORYLATION FOR THE IDENTIFICATION OF PERSONALIZED MEDICINES | KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE (SA) | 2023-10-05 | — | — | US | disclosed |
| US-11648251-B2 | TTP phosphorylation as a biomarker in targeted therapy | KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE (SA) | 2023-05-16 | — | — | US | disclosed |
| CN-112142745-B | Casein kinase 1 epsilon inhibitor, pharmaceutical composition and application thereof | 杭州和正医药有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-115413669-A | Application of kinase inhibitor and combined agent thereof in improving bacterial wilt resistance of plants | 湖南大学 | 2022-12-02 | — | — | CN | disclosed |
| CN-115413669-A | Application of kinase inhibitor and combined agent thereof in improving bacterial wilt resistance of plants | 湖南大学 | 2022-12-02 | — | — | CN | disclosed |
| US-20220251092-A1 | CASEIN KINASE 1EPSILON INHIBITOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Hangzhou Healzen Therapeutics Co., Ltd. (CN) | 2022-08-11 | — | — | US | disclosed |
| EP-3964512-A1 | CASEIN KINASE 1epsilon INHIBITOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Hangzhou Healzen Therapeutics Co., Ltd. (CN) | 2022-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220251092-A1 | CASEIN KINASE 1EPSILON INHIBITOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | CSNK1E, CSNK1A1, CSNK1G1 | MAPK14 874/4885CSNK1D 6/4885CSNK1E 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.